Navigation Links
Millennium HealthCare Appoints Ed Joyce to Company Advisory Board
Date:3/7/2012

SYOSSET, N.Y., March 7, 2012 /PRNewswire/ -- Millennium HealthCare Inc. (OTC Pink: MHCC) announced the appointment of Ed Joyce to the Company Advisory Board.

Millennium President Chris Amandola commented, "Ed brings deep experience from multiple healthcare disciplines and we are honored to have him join our advisory board.  Our Company's advantage is to have a group of highly trained, successful and resourceful individuals and he will be a tremendous addition to our team."

"Edward Joyce has over 17 years experience in medical sales and medical sales management and has a long history of success with leading medical device manufacturers such as C.R. Bard Inc., Edwards Life Sciences and St. Jude Medical.  His expertise includes, but is not limited to, managing as well as building professional sales organizations.  Throughout Edward's career he has called on numerous areas of hospitals including Infection Control, Housekeeping, Cardiology, Radiology, ICU's as well as the Operating Room.   In each of these departments Edward has built tremendous relationships across the United States and brings with him a large network of KOL's in each of these areas.  Edward has also successfully managed to launch a variety of new technology in which he had a key role in both sales related and marketing related strategies and we look forward to working together. "

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995   

Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

 


'/>"/>
SOURCE Millennium HealthCare Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting
2. Millennium Research Institute Announces 2012 Educational Initiatives
3. Millennium Surgical Corp. Provides Instruments to Latter Day Saints Charities for Humanitarian Projects
4. Millennium HealthCare Developing and Managing First Vascular Ambulatory Surgical Center
5. Millennium HealthCare Inc. Engages KBL, LLP
6. Millennium Surgical Provides Services and Support to CURE Internationals Zambian Surgical Program
7. Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx®
8. Zen Holding Corp. Changes Name to Millennium HealthCare Inc.
9. Millennium Laboratories Announces New General Counsel Martin Price and Chief Compliance Officer Janna Sipes
10. Millennium Surgicals Smart Instrument Purchasing Saves OR Personnel Time, Money
11. Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur of the Year® San Diego Finalist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 5, 2016 Special purpose needles are used in ... fluid and cells from organs or lumps and are available ... The global market for special purpose needles is showing a ... of revenue, the global special purpose needles market is projected ... period (2016–2026) and is expected to be valued at US$ ...
(Date:12/5/2016)... Dec. 5, 2016  Pennsylvania Physician General Dr. ... Programs Gary Tennis today filled prescriptions for ... Pharmacy in York to demonstrate ... Dr. Levine as a prescription to acquire naloxone at ... important to remember that any Pennsylvanian can walk up ...
(Date:12/5/2016)... -- Research and Markets has announced the addition ... (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research ... report to their offering. ... , The western blotting ... USD 574.8 Million in 2016, growing at a CAGR of 4.9%. ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... 06, 2016 , ... U.S. Security Associates (USA) was named ... their industry leading training methods that engage their associates and link their achievements ... elite in employer-sponsored training and development programs. , “The 2017 Training Top 125 ...
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 hardcover ... Lithuanian language and its poetry inspired him in writing “ Forest Lungs ... aspects of a living, breathing forest where nothing ever stays the same. His subjects ...
(Date:12/5/2016)... ... 05, 2016 , ... “Epilepsy Awareness,” which can be found ... a conversation about epilepsy, bearing down on the social stigma and lack of ... with epilepsy within their lifetime. With such a large percentage of people affected, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... BSI and Brenntag ... United States and Canada for distribution of their natural fruits and beverage ... is an exciting addition to our Life Sciences product portfolio,” said Steve Brauer, ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... portfolio company, today announced it has acquired the assets of Frankfurt, Germany ... a subsidiary of Chiltern International and focuses on clinical trial drug packaging, ...
Breaking Medicine News(10 mins):